Company intelligence
As of September 18, 2026, Angle Health was last valued at $2.7B (September 2026 Series C) and has raised at least $200M in equity across 1 sourced funding round.
Fortune dates the founding to 2019, and the company says it launched in 2021.[1],[2] Its Benefit Builder platform lets brokers generate firm, underwritten quotes in minutes.[1] The company serves more than 5,000 employers with plans available in 47 states.[1] In December 2025 it reported more than 2,600 small-business employers in 44 states.[2] Angle Health says it has grown 120% year over year and has posted four consecutive quarters of EBITDA and GAAP net income profitability.[1]
Angle Health sells AI-driven health benefits and health plans to small and midsize employers.[3] Its plans are available to employers with as few as two employees.[1] It reports nearly $1 billion in annualized premium-equivalents.[1]
Is something wrong on this page?
| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2026 | Series C | $200M | $2.7Bpost-money | TechCrunch |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
In December 2025 it raised a $134 million Series B of equity and debt led by Portage.[2] In September 2026 it announced a $600 million financing at a $2.7 billion valuation, made up of a $200 million Series C and a $400 million tender offer.[1]
Three distinct capital-stack bets on small-business insurance -- Angle Health's $600M round, Luzern Risk's $45M raise, and the previously covered Corridor seed -- landed inside the same week.
Angle Health, an AI-native health insurer built for small businesses, raised $600 million combining a $200 million Series C and a $400 million secondary tender offer, valuing the company at $2.7 billion and led by Vitruvian Partners.
In December 2025 it raised a $134 million Series B of equity and debt led by Portage.[2]
Vitruvian Partners led the round, joined by new investor Town Hall Ventures and existing investors Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator.[1]
Angle Health was co-founded by CEO Ty Wang and Anirban Gangopadhyay, both former Palantir engineers.[2]
Angle Health was last valued at $2.7B in its September 2026 Series C, according to MedCity News (September 18, 2026).
Angle Health is headquartered in San Francisco, California, USA, according to MedCity News.
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.
